Plasminogen activator inhibitor-1 (PAI-1) in children and adolescents with Type 1 Diabetes Mellitus: Relation to diabetic micro-vascular complications and carotid intima media thickness

Journal of Diabetes and its Complications

Volumn 28, Issue 3, 2014, Pages 340-347

  Adly, Amira Abdel Moneam ^a   Elbarbary, Nancy Samir ^a   Ismail, Eman Abdel Rahman ^a   Hassan, Samar Reda ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Carotid intima media thickness; Micro vascular complications; Plasminogen activator inhibitor 1; Type 1 diabetes

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADOLESCENT DISEASE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; COMMON CAROTID ARTERY; CONTROLLED STUDY; ECHOGRAPHY; EXCRETION; FEMALE; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PRIORITY JOURNAL; ALBUMINURIA; BLOOD; CAROTID ARTERY; CASE CONTROL STUDY; CHILD; COMPLICATION; DIABETIC ANGIOPATHIES; METABOLISM; MICROVASCULATURE; PATHOLOGY; PREDICTIVE VALUE; RISK FACTOR; URINE;

ADOLESCENT; ALBUMINURIA; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; MICROVESSELS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ULTRASONOGRAPHY;

EID: 84899506702     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2014.01.011     Document Type: Article

References (62)

1. S. Abdelghaffar, M. El Amir, A. El Hadidi, and F. El Mougi Carotid intima-media thickness: An index for subclinical atherosclerosis in type 1 diabetes Journal of Tropical Pediatrics 52 2006 39 45
2. R.P. Agrawal, M. Ranka, R. Beniwal, S. Sharma, V.P. Purohit, and D.K. Kochar et al. Prevalence of micro and macro complications in type 2 diabetes and their risk factors International Journal of Diabetes in Developing Countries 24 2004 11 16
3. L.M. al-Naama, M. Kadhim, and M.S. al-Aboud Lipid profile in children with insulin dependent diabetes mellitus Journal of the Pakistan Medical Association 52 2002 29 34
4. American Diabetes Association (ADA) Diagnosis and classification of diabetes mellitus Diabetes Care 33 Suppl 1 2010 S62 S69
5. M.E. Atabek, S. Kurtoglu, O. Pirgon, and M. Baykara Arterial wall thickening and stiffening in children and adolescents with type 1 diabetes Diabetes research and clinical practice 74 2006 33 40
6. J.P. Bastard, L. Pieroni, and B. Hainque Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance Diabetes/Metabolism Research and Reviews 16 2000 192 201
7. L.M. Belalcazar, C.M. Ballantyne, W. Lang, S.M. Haffner, J. Rushing, and D.C. Schwenke et al. Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: Findings from the look AHEAD study Arteriosclerosis, thrombosis, and vascular biology 31 2011 1689 1695
8. M. Cesari, M. Pahor, and R.A. Incalzi Plasminogen activator inhibitor-1 (PAI-1): A key factor linking fibrinolysis and age-related subclinical and clinical conditions Cardiovascular Therapeutics 28 2010 e72 e91
9. S. Cook, P. Auinger, and T.T. Huang Growth curves for cardio-metabolic risk factors in children and adolescents Journal of Pediatrics 155 2009 S6 S26
10. M.L. Corrêa-Giannella, and S.M. Vieira Genetic susceptibility to microangiopathy development in Type 1 diabetes mellitus Arquivos Brasileiros de Endocrinologia e Metabologia 52 2008 375 386
11. J. Coulon, D. Willems, and H. Dorchy Increase in C-reactive protein plasma levels during diabetes in infants and young adults La Presse Médicale 34 2005 89 93
12. J.R. Crouse, T.E. Craven, A.P. Hagaman, and M.G. Bond Association of coronary disease with segment specific intimal medial thickening of the extracranial carotid artery Circulation 92 1995 1141 1147
13. D.J. Crutchley, G.V. McPhee, M.F. Terris, and M.A. Canossa-Terris Levels of three hemostatic factors in relation to serum lipids. Monocyte procoagulant activity, tissue plasminogen activator, and type-1 plasminogen activator inhibitor Arteriosclerosis 9 1989 934 939
14. L.A. Distiller, B.I. Joffe, V. Melville, T. Welman, and G.B. Distiller Carotid artery intima-media complex thickening in patients with relatively long-surviving type 1 diabetes mellitus Journal of Diabetes and its Complications 20 2006 280 284
15. A.A. Eddy, and A.B. Fogo Plasminogen activator inhibitor-1 in chronic kidney disease: Evidence and mechanisms of action Journal of the American Society of Nephrology 17 2006 2999 3012
16. J.D. England, G.S. Gronseth, G. Franklin, R.G. Miller, A.K. Asbury, and G.T. Carter et al. Distal symmetric polyneuropathy: A definition for clinical research: Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation Neurology 64 2005 199 207
17. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications Diabetes 48 1999 383 390
18. A. Gils, and P.J. Declerck Plasminogen activator inhibitor-1 Current Medicinal Chemistry 11 2004 2323 2334
19. J. Gonzalez, J.C. Wood, F.J. Dorey, T.A. Wren, and V. Gilsanz Reproducibility of carotid intima-media thickness measurements in young adults Radiology 247 2008 465 471
20. P. Greenland, J. Abrams, G.P. Aurigemma, M.G. Bond, L.T. Clark, and M.H. Criqui et al. Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Noninvasive tests of atherosclerotic burden: Writing Group III Circulation 101 2000 E16 E22
21. K. Gül, I. Ustün, Y. Aydin, D. Berker, K. Erol, and M. Unal et al. Carotid intima-media thickness and its relations with the complications in patients with type 1 diabetes mellitus Anadolu Kardiyoloji Dergisi 10 2010 52 58
22. P. Gunczler, R. Lanes, E. Lopez, S. Esaa, O. Villarroel, and R. Revel-Chion Cardiac mass and function, carotid artery intima-media thickness and lipoprotein (a) levels in children and adolescents with type 1 diabetes mellitus of short duration Journal of Pediatric Endocrinology and Metabolism 15 2002 181 186
23. A. Hamsten, U. de Faire, G. Walldius, G. Dahlén, A. Szamosi, and C. Landou et al. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction Lancet 2 1987 3 9
24. C.H. Ho, and T.S. Jap Relationship of plasminogen activator inhibitor-1 with plasma insulin, glucose, triglyceride and cholesterol in Chinese patients with diabetes Thrombosis Research 69 1993 271 277
25. S. Ilic, N. Kostic, Z. Caparevic, J. Radojkovic, S. Jelic, and D. Marina Plasminogen activator inhibitor 1 and atherosclerosis in diabetes mellitus type 2 Endocrine Abstracts 20 2009 P381
26. J. Jankon, A. Al-Senaidy, and E. Skrzypczak-Jankun Can inactivators of plasminogen activator inhibitor alleviate the burden of obesity and diabetes? (Review) International Journal of Molecular Medicine 29 2012 3 11
27. M.J. Järvisalo, A. Putto-Laurila, L. Jartti, T. Lehtimäki, T. Solakivi, and T. Rönnemaa et al. Carotid artery intima-media thickness in children with type 1 diabetes Diabetes 51 2002 493 498
28. L. Jensen, B. Sloth, I. Krog-Mikkelsen, A. Flint, A. Raben, and T. Tholstrup et al. A low-glycemic-index diet reduces plasma plasminogen activator inhibitor-1 activity, but not tissue inhibitor of proteinases-1 or plasminogen activator inhibitor-1 protein, in overweight women American journal of clinical nutrition 87 2008 97 105
29. S.D. Kanters, A. Algra, and J.D. Banga Carotid intima-media thickness in hyperlipidemic type 1 and type 2 diabetic patients Diabetes Care 20 1997 276 280
30. H.I. Katcher, R.S. Legro, A.R. Kunselman, P.J. Gillies, L.M. Demers, and D.M. Bagshaw et al. The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome American journal of clinical nutrition 87 2008 79 90
31. Y. Kobayashi, Y. Fukuo, T. Shibuya, and A. Terashi The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects Nippon Ronen Igakkai Zasshi 27 1990 578 583
32. V.A. Koivisto, L.K. Stevens, M. Mattock, P. Ebeling, M. Muggeo, and J. Stephenson et al. EURODIAB Type 1 Diabetes Complications Study Group: Cardiovascular disease and its risk factors in type 1 diabetes in Europe Diabetes Care 19 1996 689 697
33. J.R. Larsen, M. Brekke, L. Bergengen, L. Sandvik, H. Arnesen, and K.F. Hanssen et al. Mean HbA1c over 18 years predicts carotid intima-media thickness in women with type 1 diabetes Diabetologia 48 2005 776 779
34. C.E. Lloyd, L.H. Kuller, D. Ellis, D.J. Becker, R.R. Wing, and T.J. Orchard Coronary artery disease in type 1 diabetes: Gender differences in risk factors, but not risk Arteriosclerosis, Thrombosis, and Vascular Biology 16 1996 720 726
35. F. Lopez-Segura, F. Velasco, J. Lopez-Miranda, P. Castro, R. Lopez-Pedrera, and A. Blanco et al. Monounsaturated fatty acid-enriched diet decreases plasma plasminogen activator inhibitor type 1 Arteriosclerosis, Thrombosis, and Vascular Biology 16 1996 82 88
36. M.W. Lorenz, S. von Kegler, H. Steinmetz, H.S. Markus, and M. Sitzer Carotid intima-media thickening indicates a higher vascular risk across a wide age range: Prospective data from the Carotid Atherosclerosis Progression Study (CAPS) Stroke 37 2006 87 92
37. C.J. Lyon, and W.A. Hsueh Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease American journal of medicine 115 Suppl. 8A 2003 62S 68S
38. R. Madan, B. Gupta, S. Saluja, U.C. Kansra, B.K. Tripathi, and B.P. Guliani Coagulation profile in diabetes and its association with diabetic microvascular complications Journal of the Association of Physicians of India 58 2010 481 484
39. H.D. Margeirsdottir, K.H. Stensaeth, J.R. Larsen, C. Brunborg, and K. Dahl-Jørgensen Early signs of atherosclerosis in diabetic children on intensive insulin treatment: A population-based study Diabetes Care 33 2010 2043 2048
40. J.B. Meigs, J. Dupuis, C. Liu, C.J. O'Donnell, C.S. Fox, and S. Kathiresan et al. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample Obesity (Silver Spring) 14 2006 753 758
41. W.G. Miller, D.E. Bruns, G.L. Hortin, S. Sandberg, K.M. Aakre, and M.J. McQueen et al. National Kidney Disease Education Program-IFCC Working Group on Standardization of Albumin in Urine. Current issues in measurement and reporting of urinary albumin excretion Clinical Chemistry 55 2009 24 38
42. M.E. Molitch, R.A. DeFronzo, M.J. Franz, W.F. Keane, C.E. Mogensen, and H.H. Parving et al. American Diabetes Association nephropathy in diabetes Diabetes Care 27 2004 S79 S83
43. J.A. Muldowney III, Q. Chen, D.L. Blakemore, and D.E. Vaughan Pentoxifylline lowers plasminogen activator inhibitor 1 levels in obese individuals: A pilot study Angiology 63 2012 429 434
44. D.K. Nagi, W.C. Knowler, R.L. Hanson, V.M. Ali, and J.S. Yudkin Plasminogen activator inhibitor (PAI-1) and non-insulin-dependent diabetes in Pima Indians, south Asians and Europeans. Populations at varying risk of NIDDM and coronary artery disease Thrombosis and Haemostasis 75 1996 921 927
45. D.M. Nathan, P.A. Cleary, J.Y. Backlund, S.M. Genuth, J.M. Lachin, and T.J. Orchard et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes New England journal of medicine 353 2005 2643 2653
46. V.A. Ploplis Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease Current Drug Targets 12 2011 1782 1789
47. A. Rogowicz-Frontczak, A. Araszkiewicz, S. Pilacinski, D. Zozulinska-Ziolkiewicz, A. Wykretowicz, and B. Wierusz-Wysocka Carotid intima-media thickness and arterial stiffness in type 1 diabetic patients with and without microangiopathy Archives of medical science 8 2012 484 490
48. E. Romuk, J. Jagosz, B. Skrzep-Poloczek, C. Wojciechowska, K. Strojek, and L. Sȩdek et al. Evaluation of VCAM-1 and PAI-1 concentration in diabetes mellitus patients Diabetologia Doświadczalna i Kliniczna 8 2008 85 88
49. Y. Schachor-Meyouhas, G. Pillar, and N. Shehadeh Uncontrolled type 1 diabetes mellitus and endothelial dysfunction in adolescents The Israel Medical Association Journal 9 2007 637 640
50. K.O. Schwab, J. Doerfer, A. Krebs, K. Krebs, E. Schorb, and K. Hallermann et al. Early atherosclerosis in childhood type 1 diabetes: Role of raised systolic blood pressure in the absence of dyslipidaemia European Journal of Pediatrics 166 2007 541 548
51. V. Sfredel, M. Mota, A. Traila, S. Danoiu, and H. Matcas Disturbances of the coagulating equilibrium of blood in diabetes mellitus Romanian Journal of Internal Medicine 37 1999 251 260
52. G. Soltesz, C. Patterson, and G. Dahlquist Diabetes in the young: A global perspective IDF diabetes atlas 4th ed. 2009 Department of Pediatrics Pecs, Hungary 1 36
53. B.P. Tabaei, A.S. Al-Kassab, L.L. llag, C.M. Zawacki, and W.H. Herman Does microalbuminuria predict diabetic nephropathy? Diabetes Care 24 2001 1560 1566
54. J.M. Tanner, R.H. Whitehouse, and M. Takaishi Standards from birth to maturity for height, weight, height velocity and weight velocity: British Children, 1965.II Archives of Disease in Childhood 41 1966 613 635
55. G. Targher, L. Bertolini, G. Zoppini, L. Zenari, and G. Falezza Increased plasma markers of inflammation and endothelial dysfunction and their association with micro-vascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy Diabetic Medicine 22 2005 999 1004
56. The Diabetes Control and Complications Trial (DCCT) Research Group Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial American journal of cardiology 75 1995 894 903
57. Third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report Circulation 106(25) 2002 3143 3421
58. V. Umpaichitra, M.M. Hussain, and S. Castells Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity Pediatric Research 58 2005 483 487
59. N. Weintrob, I. Amitay, P. Lilos, S. Shalitin, L. Lazar, and Z. Josefsberg Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes Journal of Diabetes and its Complications 21 2007 13 19
60. M.A. Wijesuriya, W.K. De-Abrew, A. Weerathunga, A. Perera, and L. Vasantharajah Association of chronic complications of type 2 diabetes with the biochemical and physical estimations in subjects attending single visit screening for complications Journal of Diabetology 2012 1 3
61. C.P. Wilkinson, F.L. Ferris III, R.E. Klein, P.P. Lee, C.D. Agardh, and M. Davis et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales Ophthalmology 110 2003 1677 1682
62. M.J. Young, A.J. Boulton, A.F. Macleod, D.R. Williams, and P.H. Sonksen A multicenter study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population Diabetologia 36 1993 150 154